Class Central is learner-supported. When you buy through links on our site, we may earn an affiliate commission.


Molecular Tumoral Board 2020-21

University of Barcelona via Coursera


Se trata de un curso que nace a raíz de una de las sesiones formativas que realiza cada 15 días el Servicio de Oncología Médica del Hospital Clínic de Barcelona (HCB). En este curso se presentan casos clínicos simulando un MTB de tumores sólidos, con un objetivo principal, mejorar el conocimiento específico del impacto clínico del perfil molecular en tumores sólidos.

Está destinado a médicos oncólogos y a estudiantes y profesionales vinculados a la oncología médica. Cada seminario que conforma el curso lo presenta un profesional de una patología diferente del Servicio de Oncología Médica del HCB.


  • GERMLIME - Breaking myths. Is lung cancer a hereditary disease?
  • MESO - How can a typical EGFR+ case, became atypical
  • BREAST - Is there any role for precision medicine in triple negative breast cancer?
  • URO-MESO - Clinical and Mutational Lanscape of Lethal Castrate Resistant prostate Cancer
  • LUNG - Off-label treatments really work?
  • PANCREAS - Precision medicine, is not only about somatic
  • COLON - Why doesn't immunotherapy work for everyone?
  • UPPER GI - Screening molecular in orphan tumors
  • BREAST - Beyond actionable mutations

Taught by

Dra. Laura Mezquita Perez and Dr. Aleix Prat Aparicio

Related Courses


Start your review of Molecular Tumoral Board 2020-21

Never Stop Learning!

Get personalized course recommendations, track subjects and courses with reminders, and more.

Sign up for free